Pear Therapeutics, Inc.’s reSET and reSET-O prescription digital therapeutics (PDTs) for the treatment of substance use disorder and opioid use disorder will be covered under Medicaid in Massachusetts.
According to Pear, this is first state Medicaid program decision to cover prescription digital therapeutics. MassHealth, the state’s agency for Medicare, has approximately two million Massachusetts residents enrolled.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?